Cochlear gene therapy targeting the protection against aging related hearing loss and neuronal degeneration

耳蜗基因疗法旨在预防与衰老相关的听力损失和神经元变性

• 批准号: 304476
• 负责人: Wang Jian
• 金额: $ 18.25万
• 依托单位: Dalhousie University (Nova Scotia)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2014
• 资助国家: 加拿大
• 起止时间: 2014-03-01 至 2016-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=304476&lang=en
• 关键词: Cochlear Gene Therapy Against Presbycusis And Noise; Deterioration In Temporal Processing With Aging; Noise Interact With Aging On Hearing Function

Age-related hearing loss (AHL), or presbycusis, impacts more than 40% of people over 65 by decreasing their communication ability as well as increasing the risk of dementia. AHL is accelerated by noise exposure. There is no medical treatment right now or

年龄相关性听力损失 (AHL) 或老年性耳聋会降低沟通能力并增加患痴呆症的风险，影响超过 40% 的 65 岁以上人群。噪音暴露会加速 AHL。目前没有治疗方法或